德琪的这种机制，相当于让T细胞变成了一个高效的“刺客”，双臂高亲和力确保能抓住那些低表达的狡猾靶点，而“快上快下”则让T细胞在完成一次击杀后迅速脱离，重新寻找下一个目标，有效避免了T细胞被过度透支。这种设计最直接的好处是大幅拓宽了药物的安全窗口。

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering ...

Biotech stocks may offer your portfolio an element of growth, and that's because these companies are sharply focused on ...

Investors are increasingly wary of the rare-disease space, spooked by a regulatory shift.

Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...

With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...

2026年3月3日星期二,Krystal Biotech (NASDAQ:KRYS)参加了TD Cowen第46届年度医疗保健会议。该公司强调了其战略增长举措,重点关注VYJUVEK销售扩张和管线推进,同时承认在定价谈判和监管流程方面面临的潜在挑战。

Puma Biotechnology (NASDAQ:PBYI)于2026年3月2日周一在TD Cowen第46届年度医疗保健会议上进行了展示,重点介绍了其扩大NERLYNX销售和推进临床管线的战略重点。该公司强调了其财务增长以及面临的挑战,包括管理药物副作用和应对监管审批途径。

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending ...

When GSK’s new CEO Luke Miels told investors last month that “smart business development” is a key pillar for his strategy, he wasn’t lying. | Like Merck & Co.’s PAH drug Winrevair—which brought in $1 ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...